Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

PaperCitations, authors & open-access status

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 522 citations, 2021 year and green oa status.

522
Citations
2021
Year
green
OA Status

Related on ScholarIQ

Christian Grohé
Author
The Lancet Respiratory Medicine
Journal
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Topic
Systemic Sclerosis and Related Diseases
Topic
Pulmonary Hypertension Research and Treatments
Topic
470M+ articles · free account